Home FDA Declines To Expand Approval Of Pfizer Arthritis Drug
 

Keywords :   


FDA Declines To Expand Approval Of Pfizer Arthritis Drug

2015-10-15 19:03:30| Biotech - Topix.net

U.S. health regulators declined to approve Pfizer Inc's oral rheumatoid arthritis drug Xeljanz to treat moderate to severe cases of the scaly skin condition plaque psoriasis, the drugmaker said on Wednesday. Pfizer said it received a so-called complete response letter from the Food and Drug Administration.

Tags: expand drug approval arthritis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
More »